Capricor Therapeutics Announces Proposed Public Offering of Common Stock - Capricor Therapeutics ( NASDAQ:CAPR )
SAN DIEGO, Oct. 16, 2024 ( GLOBE NEWSWIRE ) -- Capricor Therapeutics CAPR, a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the commencement of a proposed underwritten public offering of shares of its common ...
| Ticker |
Sentiment |
Impact |
|
META
|
Neutral
|
4 %
|
|
CAPR
|
Neutral
|
16 %
|
|
NPNKF
|
Neutral
|
4 %
|
